At a glance
- Originator Whitby Pharmaceuticals
- Developer Aderis Pharmaceuticals (CEASED)
- Class Antiarrhythmics; Cardiotonics; Neuroprotectants
- Mechanism of Action Adenosine A1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias; Myocardial infarction